Stocks
Bio-Rad Laboratories (BIO) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 5 588 | -4 489 | -654.8 | -2 142 | 1 250 | 34.6 | ||
| Changes by years, y/y, % | +10% | -180% | -85% | +227% | -158% | -24.5% | |||
Bio-Rad Laboratories. EBITDA US GAAP, bln rub
Bio-Rad Laboratories. EBITDA US GAAP, changes, %
Bio-Rad Laboratories. EBITDA US GAAP, sum by quarters, bln rub
Bio-Rad Laboratories (BIO) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 477.2 | -364.6 | 993.7 | -636.6 | 542.1 | 34.6 | |
| Changes by years, y/y, % | -117% | -140% | -217% | -577% | +14% | |||
| Changes by quarters, q/q, % | +257% | -176% | -373% | -164% | -185% | |||
